NCT04480840Phase 2Completed

Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)

Study sponsor: Pliant Therapeutics, Inc. · PLRX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-02-26Actual
Enrollment · participants121Actual
Source updated2026-01-23Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview